Dr. Andreadis on Developments to CAR T-Cell Therapy – OncLive
OncLive |
Dr. Andreadis on Developments to CAR T-Cell Therapy
OncLive Charalambos (Babis) Andreadis, MD, MSCE, associate professor of clinical medicine, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, discusses developments being made to chimeric antigen receptor (CAR) T-cell therapy for … |
